Holen Sie sich die Stockscreener-App
1.25
4.58%
-0.06
Handel nachbörslich:
1.20
-0.05
-4.00%
Schlusskurs vom Vortag:
$1.31
Offen:
$1.32
24-Stunden-Volumen:
58,001
Relative Volume:
1.07
Marktkapitalisierung:
$36.05M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-0.7975
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
-15.54%
1M Leistung:
-3.10%
6M Leistung:
-67.45%
1J Leistung:
-13.79%
1-Tages-Spanne:
$1.21
$1.32
1-Wochen-Bereich:
$1.21
$1.4857
52-Wochen-Spanne:
$1.01
$4.35
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Compare CELU vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.25 | 37.78M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Guidance Update: How do insiders feel about Celularity IncWeekly Trade Summary & Real-Time Volume Spike Alerts - baoquankhu1.vn
Treasury Yields: Can Celularity Inc maintain sales growthMarket Activity Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Earnings Beat: Should I buy Epsium Enterprise Limited stock nowWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn
Trend Review: Can Celularity Inc Equity Warrant keep up with sector leaders2025 Technical Patterns & Weekly High Conviction Ideas - baoquankhu1.vn
Risk Off: Is MiMedx Group Inc stock a smart retirement pickCPI Data & Precise Buy Zone Tips - baoquankhu1.vn
Investor Mood: What is Celularity Inc Equity Warrants revenue forecast2025 Price Action Summary & Real-Time Volume Analysis - baoquankhu1.vn
Valuation Update: How does VOXR perform in inflationary periodsTrade Signal Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Market Fear: Is Celularity Inc stock risky to hold nowJuly 2025 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn
Breakout Watch: Can Celularity Inc maintain sales growthMarket Risk Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Trading Recap: Can Celularity Inc maintain sales growthTrade Entry Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Will Celularity Inc. Equity Warrant benefit from AI trendsWeekly Profit Analysis & Community Trade Idea Sharing Platform - mfd.ru
Will Celularity Inc. Equity Warrant stock recover after earningsPortfolio Gains Report & Smart Swing Trading Alerts - mfd.ru
Aug Ideas: Why is DAVA stock going down2025 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Volume Recap: Can Celularity Inc stock outperform in a bear marketJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Is Celularity Inc. Equity Warrant benefiting from interest rate changes2025 Performance Recap & Weekly Setup with High ROI Potential - mfd.ru
Market Review: Is Celularity Inc Equity Warrant backed by strong institutional buying2025 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Celularity receives $12.2 million from sale of tax credits - Investing.com Australia
Celularity receives $12.2 million from sale of tax credits By Investing.com - Investing.com South Africa
Celularity of Florham Park gets $12.2M from sale of New Jersey net operating losses - ROI-NJ
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses - Investing News Network
Celularity Receives $12.2 Million From Sale Of New Jersey Net Operating Losses - TradingView
Celularity Inc. Secures $12.2 Million from Sale of New Jersey Net Operating Losses and R&D Tax Credits - Quiver Quantitative
New Jersey tax program delivers $12.2M boost to Celularity - Stock Titan
Aug Wrap: Is Celularity Inc showing insider buyingJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
Loss Report: Will Celularity Inc Equity Warrant benefit from AI trendsGap Down & Technical Pattern Based Buy Signals - baoquankhu1.vn
Highs Report: Why is Celularity Inc stock going upWeekly Earnings Recap & Growth Oriented Trading Recommendations - baoquankhu1.vn
Is Celularity Inc Equity Warrant a top pick in the sector2025 Earnings Surprises & Accurate Technical Buy Alerts - baoquankhu1.vn
Winners Losers: Does Celularity Inc. Equity Warrant have pricing power - baoquankhu1.vn
New Highs: Will Celularity Inc Equity Warrant stock recover after earningsJuly 2025 Outlook & Community Verified Watchlist Alerts - baoquankhu1.vn
Published on: 2026-02-02 09:28:36 - baoquankhu1.vn
VIX Spike: Does EF Hutton Acquisition Corporation I Equity Warrant have consistent dividend growthJuly 2025 Setups & Weekly High Potential Alerts - baoquankhu1.vn
Volume Summary: What drives Oriental Culture Holding LTDs stock priceJuly 2025 Momentum & Capital Protection Trade Alerts - baoquankhu1.vn
Stock Recap: Will ATYR outperform the market in YEARJuly 2025 Snapshot & Risk Controlled Stock Alerts - baoquankhu1.vn
VIX Spike: What drives Celularity Incs stock priceMarket Risk Report & Long Hold Capital Preservation Plans - baoquankhu1.vn
Market Trends: Is Celularity Inc Equity Warrant impacted by rising ratesQuarterly Portfolio Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Can Ernexa Therapeutics Inc. be recession proofJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
What is the cash position of Southside Bancshares IncTrade Entry Summary & Community Driven Trade Alerts - baoquankhu1.vn
Movement Recap: Is Celularity Inc a stock for growth or value investors2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Is Celularity Inc. Equity Warrant stock a smart buy before Fed meetingWatch List & Reliable Entry Point Trade Alerts - Bollywood Helpline
Why Celularity Inc. Equity Warrant stock could rally in 20252025 EndofYear Setup & Safe Capital Preservation Plans - Bollywood Helpline
Downgrade Watch: How does Celularity Inc Equity Warrant perform in inflationary periodsPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Risk On: Will Celularity Inc benefit from government policyJuly 2025 Volume & Long-Term Investment Growth Plans - baoquankhu1.vn
Weekly Earnings: Does Celularity Inc meet Warren Buffetts criteriaWeekly Profit Analysis & Daily Profit Maximizing Tips - baoquankhu1.vn
Volume Report: What is Celularity Inc Equity Warrants revenue forecastJuly 2025 Sentiment & Risk Controlled Swing Alerts - baoquankhu1.vn
Pullback Watch: How Celularity Inc Equity Warrant stock responds to policy changes2025 Winners & Losers & Safe Entry Zone Tips - Bộ Nội Vụ
Revenue Check: What is Celularity Inc Equity Warrants market position2025 Key Highlights & Reliable Intraday Trade Plans - baoquankhu1.vn
Is Celularity Inc. Equity Warrant stock a buy in volatile markets2025 Price Momentum & Accurate Trade Setup Notifications - Улправда
Will Celularity Inc. stock split attract more investorsFootwear buying guidance for recovery days and low impact training focuses on balanced cushioning and support, making it helpful for judging overall value. - ulpravda.ru
Why Celularity Inc. Equity Warrant stock could see breakout soonJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - Улправда
Will Celularity Inc. stock gain from strong economyJuly 2025 Earnings & Technical Pattern Recognition Alerts - Улправда
Celularity receives FDA warning over marketing claims - MSN
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):